AIM: Meta-analyses have been used to evaluate associations between polymorphisms and colorectal cancer risk, but the quality of individual studies used to inform them may vary substantially. Our aim was to apply well-established quality-control criteria to individual association studies and then compare the results of meta-analyses that included or excluded studies that did not meet these criteria. METHOD: We used meta-analyses of studies reporting a relationship between polymorphisms and colorectal cancer published between 1996 and 2008. Polymorphism-cancer associations were derived in separate meta-analyses including only those meeting the quality-control criteria. RESULTS: Relative ORs varied substantially between the open and restricted group meta-analyses for all variants except MTHFR 677 CT. However, the associations were modest and the direction of relative risk did not change after applying criteria. Publication bias was detected for all associations, except the restricted set of studies for GSTP1 GG. CONCLUSION: We observed variation in calculated relative risk and changes in tests for publication bias that were dependent on the inclusion criteria used for association studies of polymorphisms and colorectal cancer. Standardizing study inclusion criteria may reduce the variation in findings for meta-analyses of gene-association studies of common diseases such as colorectal cancer.
AIM: Meta-analyses have been used to evaluate associations between polymorphisms and colorectal cancer risk, but the quality of individual studies used to inform them may vary substantially. Our aim was to apply well-established quality-control criteria to individual association studies and then compare the results of meta-analyses that included or excluded studies that did not meet these criteria. METHOD: We used meta-analyses of studies reporting a relationship between polymorphisms and colorectal cancer published between 1996 and 2008. Polymorphism-cancer associations were derived in separate meta-analyses including only those meeting the quality-control criteria. RESULTS: Relative ORs varied substantially between the open and restricted group meta-analyses for all variants except MTHFR 677 CT. However, the associations were modest and the direction of relative risk did not change after applying criteria. Publication bias was detected for all associations, except the restricted set of studies for GSTP1 GG. CONCLUSION: We observed variation in calculated relative risk and changes in tests for publication bias that were dependent on the inclusion criteria used for association studies of polymorphisms and colorectal cancer. Standardizing study inclusion criteria may reduce the variation in findings for meta-analyses of gene-association studies of common diseases such as colorectal cancer.
Authors: Carmen Martínez; Felipe Martín; Juana M Fernández; Elena García-Martín; Javier Sastre; Manuel Díaz-Rubio; José Ag Agúndez; José M Ladero Journal: Pharmacogenomics Date: 2006-07 Impact factor: 2.533
Authors: R Rajagopal; M Deakin; A S Fawole; J B Elder; J Elder; V Smith; R C Strange; A A Fryer Journal: Carcinogenesis Date: 2005-07-28 Impact factor: 4.944
Authors: Xiao-Feng Sun; Ahmad Ahmadi; Gunnar Arbman; Asa Wallin; Daniel Asklid; Hong Zhang Journal: World J Gastroenterol Date: 2005-11-21 Impact factor: 5.742
Authors: D A Bell; E A Stephens; T Castranio; D M Umbach; M Watson; M Deakin; J Elder; C Hendrickse; H Duncan; R C Strange Journal: Cancer Res Date: 1995-08-15 Impact factor: 12.701
Authors: Milica Lj Stojkovic Lalosevic; Vesna M Coric; Tatjana D Pekmezovic; Tatjana P Simic; Marija S Pljesa Ercegovac; Aleksandra R Pavlovic Markovic; Zoran V Krivokapic Journal: Pathol Oncol Res Date: 2019-01-29 Impact factor: 3.201